Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $314.77 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $64.94 | 4 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $61.43 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.98 | 2 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $19.72 | 1 | $0 (2017) |
| UCB, Inc. | $19.50 | 1 | $0 (2019) |
| Braintree Laboratories, Inc. | $18.95 | 1 | $0 (2019) |
| Wilmington Medical Supply, Inc. | $17.19 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.21 | 1 | $0 (2020) |
| GENZYME CORPORATION | $15.55 | 1 | $0 (2017) |
| Nestle HealthCare Nutrition Inc. | $14.54 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.67 | 1 | RedHill Biopharma Inc. ($13.67) |
| 2022 | $41.63 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($14.91) |
| 2020 | $29.28 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16.21) |
| 2019 | $144.88 | 8 | Endo Pharmaceuticals Inc. ($61.43) |
| 2018 | $37.13 | 2 | AbbVie, Inc. ($19.94) |
| 2017 | $48.18 | 3 | Dendreon Pharmaceuticals LLC ($19.72) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2023 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Antibiotic | ||||||
| 12/05/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/10/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2019 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUPREP BOWEL PREP | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 08/12/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Endocrinology | ||||||
| 07/16/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 07/16/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 06/24/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $16.17 | General |
| 04/08/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 02/14/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 01/28/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Endocrinology | ||||||
| 12/03/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Endocrinology | ||||||
| 01/16/2018 | Wilmington Medical Supply, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| 11/13/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/20/2017 | GENZYME CORPORATION | PROSTATE CANCER - DISEASE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| 02/22/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 247 | 256 | $606,336 | $25,217 |
| 2022 | 4 | 285 | 290 | $688,019 | $30,943 |
| 2021 | 4 | 147 | 149 | $385,290 | $17,753 |
| 2020 | 5 | 283 | 284 | $421,965 | $33,337 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 119 | 125 | $349,868 | $12,742 | 3.6% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 102 | 105 | $215,284 | $10,259 | 4.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 26 | 26 | $41,184 | $2,216 | 5.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 124 | 129 | $355,339 | $13,798 | 3.9% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 111 | 111 | $228,964 | $11,000 | 4.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 38 | 38 | $65,698 | $4,230 | 6.4% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 12 | 12 | $38,018 | $1,916 | 5.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 57 | 59 | $170,056 | $6,619 | 3.9% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 44 | 44 | $93,156 | $4,771 | 5.1% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 30 | 30 | $75,339 | $3,760 | 5.0% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 16 | 16 | $46,739 | $2,602 | 5.6% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 103 | 103 | $148,120 | $11,585 | 7.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 82 | 83 | $133,170 | $10,119 | 7.6% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2020 | 54 | 54 | $73,285 | $6,190 | 8.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2020 | 27 | 27 | $47,840 | $3,987 | 8.3% |
| 00910 | Anesthesia for procedure on urinary system including use of an endoscope | Office | 2020 | 17 | 17 | $19,550 | $1,456 | 7.4% |
About Dr. Chhaya Dave, M.D
Dr. Chhaya Dave, M.D is a Anesthesiology healthcare provider based in Willingboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184608549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chhaya Dave, M.D has received a total of $314.77 in payments from pharmaceutical and medical device companies, with $13.67 received in 2023. These payments were reported across 19 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($314.77).
As a Medicare-enrolled provider, Dave has provided services to 962 Medicare beneficiaries, totaling 979 services with total Medicare billing of $107,250. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology
- Location Willingboro, NJ
- Active Since 11/30/2005
- Last Updated 03/13/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1184608549
Products in Payments
- NASCOBAL (Drug) $61.43
- Creon (Drug) $48.77
- ENTYVIO (Biological) $27.98
- PROVENGE (Drug) $19.72
- Cimzia (Drug) $19.50
- MOTOFEN (Drug) $18.95
- XIFAXAN (Drug) $16.21
- PROSTATE CANCER - DISEASE (Drug) $15.55
- ZENPEP (Drug) $14.54
- Talicia (Drug) $13.67
- ZYTIGA (Drug) $12.91
- OCALIVA (Drug) $12.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.